Search
for
Sort by
Research 181–210 of 1000+
- Neutrophil extracellular traps impair regeneration
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions
- Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
- Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- A Comprehensive Review of GWASs of Human Hair Traits
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: e-Posters
- Somatotropin Penetration Testing from Formulations Applied Topically to the Skin
- Enhancing Quercetin Bioavailability Attenuates Aging Phenotypes via the Gut Microbiota–Intestinal Barrier Axis in Aged Mice
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Enhancing Quercetin Bioavailability Attenuates Aging Phenotypes via the Gut Microbiota–Intestinal Barrier Axis in Aged Mice
- The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives
- Ancient botanicals and the skin: Defining dermatologic ethnophytoconvergence as a translational framework for pharmacognosy
- A Decade of Autologous Micrografting Technology in Hair Restoration: A Review of Clinical Evidence and the Evolving Landscape of Regenerative Treatments
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
- Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata